Literature DB >> 29313854

Surgery for small cell lung cancer in the modern era: opportunities and challenges.

Elliot Wakeam1.   

Abstract

Entities:  

Year:  2017        PMID： 29313854      PMCID： PMC5757071          DOI： 10.21037/jtd.2017.11.23

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  11 in total

1.  Indications for Adjuvant Mediastinal Radiotherapy in Surgically Resected Small Cell Lung Cancer.

Authors:  Elliot Wakeam; Meredith Giuliani; Natasha B Leighl; Samuel R G Finlayson; Thomas K Varghese; Gail E Darling
Journal:  Ann Thorac Surg       Date:  2017-03-03       Impact factor: 4.330

2.  Trends in stereotactic body radiation therapy for stage I small cell lung cancer.

Authors:  John M Stahl; Christopher D Corso; Vivek Verma; Henry S Park; Sameer K Nath; Zain A Husain; Charles B Simone; Anthony W Kim; Roy H Decker
Journal:  Lung Cancer       Date:  2016-11-16       Impact factor: 5.705

Review 3.  Recent developments in radiotherapy for small-cell lung cancer: a review by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).

Authors:  N Rodriguez de Dios; P Calvo; M Rico; M Martín; F Couñago; A Sotoca; B Taboada; A Rodríguez
Journal:  Clin Transl Oncol       Date:  2017-04-26       Impact factor: 3.405

4.  Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up.

Authors:  W Fox; J G Scadding
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

5.  Under-treatment of small cell lung cancer: the case for surgical resection.

Authors:  Kathryn E Engelhardt; David D Odell; Malcolm M DeCamp
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

6.  Surgery for limited-stage small cell lung cancer: ready for prime-time?

Authors:  Vinicius Ernani; Apar Kishor Ganti
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

7.  Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.

Authors:  E Wakeam; S A Acuna; N B Leighl; M E Giuliani; S R G Finlayson; T K Varghese; G E Darling
Journal:  Lung Cancer       Date:  2017-05-01       Impact factor: 5.705

8.  The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer.

Authors:  Eric Vallières; Frances A Shepherd; John Crowley; Paul Van Houtte; Pieter E Postmus; Desmond Carney; Kari Chansky; Zeba Shaikh; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2009-09       Impact factor: 15.609

9.  A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy.

Authors:  T Lad; S Piantadosi; P Thomas; D Payne; J Ruckdeschel; G Giaccone
Journal:  Chest       Date:  1994-12       Impact factor: 9.410

10.  Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.

Authors:  Corinne Faivre-Finn; Michael Snee; Linda Ashcroft; Wiebke Appel; Fabrice Barlesi; Adityanarayan Bhatnagar; Andrea Bezjak; Felipe Cardenal; Pierre Fournel; Susan Harden; Cecile Le Pechoux; Rhona McMenemin; Nazia Mohammed; Mary O'Brien; Jason Pantarotto; Veerle Surmont; Jan P Van Meerbeeck; Penella J Woll; Paul Lorigan; Fiona Blackhall
Journal:  Lancet Oncol       Date:  2017-06-20       Impact factor: 41.316
View more
  2 in total

1.  Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.

Authors:  Long Xu; Guanzhong Zhang; Shuxi Song; Zhendong Zheng
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

2.  Comparison of treatment strategies for patients with limited-stage small cell lung cancer who received chemotherapy.

Authors:  Shenhai Wei; Bo Wei; Jintao Tian; Xiaoping Song; Bingqun Wu; Pengcheng Hu
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.